BioSpace News Archive

Genetown

CENTOGENE, University College London, and Global Team of Researchers Discover Gene Associated With New Neurodevelopmental Disease Linked to Early-Onset Dystonia and Parkinsonism

Centogene N.V. announced the discovery of a new form of early-onset dystonia and parkinsonism in the context of neurodevelopmental abnormalities associated to the gene called ACBD6 as part of an international team of researchers.

November 14, 2023
·
6 min read
Biotech Beach

MBrace Therapeutics Raises $85 Million Series B Financing to Advance Oncology Pipeline of Innovative Antibody Drug Conjugate Candidates

MBrace™ Therapeutics, Inc. announced the completion of an $85 million Series B financing, bringing the company’s total raised to $110 million.

November 14, 2023
·
3 min read
Pharm Country

EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases

Eyebiotech Limited (“EyeBio” or “the Company”), a privately held clinical-stage ophthalmology biotechnology company working to deliver a new generation of therapies for eye diseases, today announced the successful close of an extension to its Series A financing, bringing the total raised to date to $130 million.

November 14, 2023
·
5 min read
Pharm Country

Hoth Therapeutics Announces Successful Completion of Pre-IND Meeting with FDA Regarding Development of Hoth’s Cancer Fighting HT-KIT

Hoth Therapeutics, Inc. today announced today the successful completion of a pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding the Company’s development plan for its HT-KIT therapeutic.

November 14, 2023
·
5 min read
BioMidwest

Progress on GeoVax’s Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023

GeoVax Labs, Inc. announced the presentation of preclinical vaccine efficacy data for GEO-CM02, a multi-antigen investigational SARS-CoV-2 vaccine.

November 14, 2023
·
7 min read
Drug Development

Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in Rheumatoid Arthritis(Phase II Multicenter Study is Proceeding Well with High Anticipation)

XBiotech announced that Alan Kivitz M.D. is now Lead Investigator & Study Chairman for its clinical research program for Natrunix in Rheumatoid Arthritis.

November 14, 2023
·
5 min read
Business

Shuttle Pharmaceuticals Provides Third Quarter 2023 Corporate Update

Shuttle Pharmaceuticals Holdings, Inc. today provided a corporate update in connection with the filing of its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023.

November 14, 2023
·
6 min read
Lexogen Unveils LUTHOR High-Definition Single Cell 3' mRNA-Seq Kit, Revolutionizing Single-Cell RNA Sequencing

Lexogen, a pioneer in the field of genomics and transcriptomics, is proud to introduce the groundbreaking LUTHOR High-Definition Single Cell 3' mRNA-Seq Kit, a game-changing innovation that sets new standards in single-cell RNA sequencing.

November 14, 2023
·
3 min read
Bio NC

IQVIA Announces Offering of Senior Secured Notes - November 14, 2023

IQVIA Holdings Inc. announced that its wholly-owned subsidiary, IQVIA Inc., intends to raise $500,000,000 through an offering of senior secured notes due 2029.

November 14, 2023
·
4 min read
BioMark Strengthens and Expands Its Strategic Advisory Team in Pursuit of Commercialization Initiatives

November 14, 2023) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) (“BioMark”) an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased to announce today the appointment of Dr. Randolph Ford to its Strategic Advisory

November 14, 2023
·
4 min read